Drug recall
Calcium Acetate Capsules, 667 mg, 200 Capsules per bottle, Rx Only. Manufactured by Nostrum Laboratories, Inc…
FDA recall event 79210 · Class III · Nostrum Laboratories Inc
Key facts
| Event ID | 79210 |
|---|---|
| Recall numbers | D-0473-2018 |
| Recalling firm | Nostrum Laboratories Inc |
| Product type | Drugs |
| Products | Calcium Acetate Capsules, 667 mg, 200 Capsules per bottle, Rx Only. Manufactured by Nostrum Laboratories, Inc. Kansas City, MO 64120. NDC 29033-026-02 |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Presence of Foreign Tablets/Capsules |
| Initiation date | Feb 13, 2018 |
| Report date | Feb 28, 2018 |
| Termination date | Dec 13, 2018 |
| City | Kansas City |
| State | MO |
| Country | United States |
| FEI number | 1930436 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: